Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Drug Design, Development and Therapy|June 5, 2018
REST, not REST4, is a risk factor associated with radiotherapy plus chemotherapy efficacy in gliomaCuilin Li, Hecun Zou, Zhifei Wang, et al.
Drug Metabolism Reviews|January 28, 2020
Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivitiesLi Yang, Hecun Zou, Yongchao Gao, et al.
Oncology Reports|December 6, 2017
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomasHecun Zou, Chunjie Wen, Zhigang Peng, et al.
Biosensors & Bioelectronics|September 24, 2025
A ratiometric fluorescent paper-based sensor based on Fe/Eu-MOF for visual and sensitive detection of diethylstilbestrolDongmei Liu, Xinhui Jiang, Xiaoming Li, et al.
Aging|March 7, 2024
The tsRNAs (tRFdb-3013a/b) serve as novel biomarkers for colon adenocarcinomasLihong Tan, Xiaoling Wu, Zhurong Tang, et al.
Biosensors & Bioelectronics|December 2, 2025
Self-confined catalytic DNA circuit for on-site nonenzymatic amplified microRNA imagingXue Hu, Mingmeng Xie, Yuxiang Lang, et al.
Frontiers in Immunology|October 5, 2020
The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor ProgressionZeyu Wang, Xing Wang, Hecun Zou, et al.
Cell Death & Disease|June 18, 2022
Ct-OATP1B3 promotes high-grade serous ovarian cancer metastasis by regulation of fatty acid beta-oxidation and oxidative phosphorylationYutang Huang, Yan Du, Yujie Zheng, et al.
Oncotarget|January 2, 2018
Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomasShuang Li, Hecun Zou, Ying-Ying Shao, et al.
Oncotarget|November 8, 2017
lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patientsHecun Zou, Lan-Xiang Wu, Yonglong Yang, et al.
Pageof 3